A spokesperson for 23andMe would not comment to NPR on what will happen to genetic data, except to express the company’s ...

Twenty-five European universities have launched a Network which aims to equip more than 10,000 medical students with the ...

Research analysts at Zacks Research reduced their Q1 2026 EPS estimates for shares of GSK in a report issued on Wednesday, ...

“Additionally, consumers will also get to take advantage of RHEA Generics’ wide availability at 1,200 Mercury Drug outlets ...

With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

The vaccine that’s helped protect millions of people worldwide from the COVID-19 virus and its variants would not have been ...